Corpus Intelligence IC Memo — BURNETT MEDICAL CENTER INC 2026-04-26 17:27 UTC
IC Memo — BURNETT MEDICAL CENTER INC
Investment Committee Memorandum | WI | 25 beds | Grade D | EBITDA uplift $1.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BURNETT MEDICAL CENTER INC

CCN 521331 | BURNETT, WI | 25 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BURNETT MEDICAL CENTER INC is a 25-bed rural/critical access in BURNETT, WI with $24.4M in net patient revenue and a 6.0% operating margin. The hospital serves a payer mix of 64.1% Medicare, 1.2% Medicaid, and 34.7% commercial.

Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 6.0% to 13.4% (+736bps).

Net Revenue HCRIS$24.4M
Current EBITDA COMPUTED$1.5M
Operating Margin COMPUTED6.0%
Occupancy HCRIS11.1%
Revenue / Bed COMPUTED$976K
Net-to-Gross HCRIS60.1%
Distress Probability ML61.2%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
87
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of 6.0% places it above the state median. Among 87 size-comparable peers (12-50 beds), the median margin is 1.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 87 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BURNETT MEDICAL CENTER INC (Target)WI25$24.4M6.0%
MERCY WALWORTH HOSPITALWI25$616.4M4.4%
ASPIRUS RIVERVIEW HOSPITAL & CWI44$161.3M13.1%
MEMORIAL MEDICAL CENTER INC.WI25$138.4M8.1%
LAKEVIEW MEDICAL CENTER OF RICWI40$137.4M-12.0%
MARSHFIELD MEDICAL CENTER-MINOWI19$129.6M-12.4%
FORT ATKINSON MEMORIAL HOSPITAWI49$127.0M-10.1%
MCHS-RED CEDARWI25$123.4M16.8%
MEMORIAL HOSPITAL OF BURLINGTOWI33$118.8M15.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$512K+210bp18mo
Cost to Collect4.5%2.5%$488K+200bp12mo
Denial Rate Reduction12.0%6.5%$483K+198bp12mo
A/R Days Reduction5200.0%3800.0%$297K+122bp9mo
Clean Claim Rate88.0%96.0%$16K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$512K
Cost to Collect
$488K
Denial Rate Reduction
$483K
A/R Days Reduction
$297K
Clean Claim Rate
$16K
Total EBITDA Uplift$1.8M
Current EBITDA$1.5M
+ RCM Uplift+$1.8M
Pro Forma EBITDA$3.3M
Current Margin6.0%
Pro Forma Margin13.4%
WC Released (1x)$935K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$2.3M$27.6M12.24x65.0%
Base (11x exit)10.0x11.0x$2.3M$31.1M13.78x69.0%
Bull Case9.0x11.0x$2.0M$37.8M18.59x79.4%
Bull (12x exit)9.0x12.0x$2.0M$41.8M20.58x83.1%
Bear Case11.0x10.0x$2.5M$17.9M7.22x48.5%
Bear (11x exit)11.0x11.0x$2.5M$20.5M8.26x52.5%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 64.1% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 11.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 61.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 87 hospitals with 12-50 beds
  • Same-state prioritization (n=88)
  • Comp margins: P25=-10.1% / P50=1.2% / P75=8.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.